Merck

KEYTRUDA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / KEYTRUDA – J9271

Manufacturer:

Merck

Name:

KEYTRUDA

HCPCS Code Descriptor:

Injection, pembrolizumab, 1 mg

Category:

J Code

HCPCS:

J9271

NDC(s):

00006-3026-04, 00006-3026-02

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

KEYTRUDA is an Oncology drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J9271 is aligned to the drug KEYTRUDA.

Keytruda is a cancer drug that is used to treat numerous types of cancer and can be used by itself or with other cancer medications. This medication works by stopping the growth of the cancer cells. Keytruda is administered by infusion into the vein over the course of at least thirty minutes. Keytruda is manufactured by Merck Sharp & Dohme Corporation and is a branded drug. Patient assist programs for Keytruda can be found through Merck.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/16

HCPCS Short Description:

Inj pembrolizumab

Billing and Coding Guide:

https://www.keytrudahcp.com/resources/hcp-and-patient-resources/

Patient Assistance:

https://www.merckaccessprogram-keytruda.com/hcc/

KEYTRUDA - J9271